Krónikus vesebetegség: vizsgálatok itt: Argentína

11 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Where

  Buenos Aires, CABA, Ciudad Autónoma de Bs. As., Ciudad de Buenos Aires, Córdoba, Lanus, Lanús Este, La Plata, Mar del Plata, Rosario, San Nicolás, Santa Fe, Santiago del Estero, Temperley

  Életkor

  18 év and over

  People

  5000 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06742723 · EU 2023-506460-14-00
• 3. fázisTaking people
  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  Where

  Bahía Blanca, Buenos Aires, C.a.b.a., CABA, Córdoba, Corrientes, Esperanza, Godoy Cruz, Granadero Baigorria, Junín, Lanus, Mar del Plata, Mendoza, Quilmes, Ramos Mejía, Río Cuarto, Rosario, S3000epv, San Isidro, San Martin, SAN M. de Tucuman, San Miguel de Tucumán, San Nicolás, Santa Fe, Santa Rosa, Venado Tuerto, Zárate

  Életkor

  50 év and over

  People

  7140 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07241390 · EU 2025-523123-22-00
• No phaseCsak meghívásos
  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  Where

  Buenos Aires

  Életkor

  0 Minutes to 2 hét

  People

  8000 worldwide

  Run by

  Indiana University

  See details and how to joinNCT06823115
• 3. fázisTaking people
  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Where

  CABA, Córdoba, Santa Fe

  Életkor

  18 év to 100 év

  People

  540 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04557462 · EU 2023-508690-92-00
• 3. fázisTaking people
  A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

  Where

  Buenos Aires, San Luis, Santa Fe

  Életkor

  1 év to 18 év

  People

  100 worldwide

  Run by

  Bayer

  See details and how to joinNCT05457283 · EU 2023-504885-50-00
• 3. fázisTaking people
  A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  Where

  CABA, Capital Federal, Ciudad de Buenos Aires, Lanús Este, La Plata, Mar del Plata, Rosario, San Nicolás, Santa Fe

  Életkor

  18 év to 99 év

  People

  2800 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07624305 · EU 2026-526114-90-00
• 2/3. fázisTaking people
  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Where

  Banfield, Buenos Aires, Ciudad Autonoma, Ciudad de Buenos Aires, Ciudad Evita, Córdoba, Formosa, Hurlingham, Mar del Plata, Morón, Rosario, San Fernando, San Miguel de Tucumán, Santa Fe

  Életkor

  18 év and over

  People

  3110 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT05485961 · EU 2022-500273-14-00
• 3. fázisTaking people
  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  Where

  Buenos Aires, CABA, Ciudad de Buenos Aires, Córdoba, La Plata, Mar del Plata, Rosario, San Nicolás, Santa Rosa

  Életkor

  18 év and over

  People

  7000 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07753993 · EU 2025-523994-41-00
• 2. fázisTaking people
  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  Where

  City of Buenos Aires, Corrientes, Lanús Este, Mar del Plata

  Életkor

  18 év and over

  People

  465 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06717698 · EU 2024-510846-15-00
• 3. fázisTaking people
  A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

  Where

  Belen de Escobar, Cuidad Autonoma de Buenos Aires, San Miguel de Tucumán

  Életkor

  0 év to 18 év

  People

  56 worldwide

  Run by

  Amgen

  See details and how to joinNCT03633708
• 2. fázisTaking people
  Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

  Where

  Buenos Aires

  Életkor

  18 év to 70 év

  People

  80

  Run by

  Maximo Agustin Schiavone

  See details and how to joinNCT06929169